MedDataX Logo

Universal Screening for Tuberculosis and Anemia With the CHICA System

NCT ID: NCT01322841

Last Updated: 2016-12-02

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

2239 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-10-31

Study Completion Date

2010-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The CHICA system is a clinical decision support system that uses adaptive turnaround documents to provide point-of-care information to clinicians. The investigators will be studying whether it can help in the diagnosis and treatment of tuberculosis and iron deficiency anemia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The CHICA system is a clinical decision support system that uses adaptive turnaround documents to provide point-of-care information to clinicians. We will be studying whether it can help in the diagnosis and treatment of tuberculosis and iron deficiency anemia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tuberculosis Iron Deficiency Anemia

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

CHICA clinical decision support

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CHICA Diagnosis Module

This arm had the CHICA screening module turned on

Group Type ACTIVE_COMPARATOR

CHICA Diagnosis Module

Intervention Type OTHER

The CHICA module helped to screen and diagnose patients with tuberculosis or iron deficiency anemia

CHICA Placebo

This arm had CHICA but no additional module

Group Type PLACEBO_COMPARATOR

CHICA Placebo

Intervention Type OTHER

This was CHICA without the screening module

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CHICA Diagnosis Module

The CHICA module helped to screen and diagnose patients with tuberculosis or iron deficiency anemia

Intervention Type OTHER

CHICA Placebo

This was CHICA without the screening module

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Age 3 to 11 years old and seen in a study clinic

Exclusion Criteria

None
Minimum Eligible Age

3 Years

Maximum Eligible Age

11 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Library of Medicine (NLM)

NIH

Sponsor Role collaborator

Indiana University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Aaron Carroll

Professor of Pediatrics

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Aaron E Carroll, MD, MS

Role: PRINCIPAL_INVESTIGATOR

IUSM

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Children's Health Services Research

Indianapolis, Indiana, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5K22LM009160

Identifier Type: NIH

Identifier Source: secondary_id

View Link

CHICA_Screening

Identifier Type: -

Identifier Source: org_study_id